Assessment of the reporting quality of RCTs for novel oral anticoagulants in venous thromboembolic disease based on the CONSORT statement

2019 ◽  
Vol 48 (4) ◽  
pp. 542-553 ◽  
Author(s):  
Ioannis Liampas ◽  
Antonios Chlinos ◽  
Vasileios Siokas ◽  
Alexandros Brotis ◽  
Efthimios Dardiotis

Venous thrombosis 512 Venous thromboembolic disease (VTE) includes thrombosis of superficial and deep veins (DVT), usually of the leg, thigh, and pelvis, pulmonary embolus (PE) and thrombosis associated with central venous catheters (CVCs). Venous thrombosis can have a profound impact on a cancer patient's quality of life. It is a well recognized, major complication of cancer and the second leading cause of death in hospitalized patients with cancer. It remains an under-diagnosed and under-treated condition....


2012 ◽  
Vol 24 (3) ◽  
pp. 133-142
Author(s):  
Alexandra Yannoutsos ◽  
Claire Le Jeunne ◽  
Marc Samama ◽  
Jacques Blacher

2020 ◽  
Vol 415 ◽  
pp. 116938 ◽  
Author(s):  
Michalis Kodounis ◽  
Ioannis N. Liampas ◽  
Theodoros S. Constantinidis ◽  
Vasileios Siokas ◽  
Alexios-Fotios A. Mentis ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document